EVIDENCE FOR AUTOCRINE GROWTH-STIMULATION BY A GASTRIN CCK-LIKE PEPTIDE OF THE GASTRIC-CANCER HGT-1 CELL-LINE

被引:17
作者
REMYHEINTZ, N
PERRIERMEISSONNIER, S
NONOTTE, I
LALIBERTE, MF
CHEVILLARD, C
LABOISSE, C
BALI, JP
机构
[1] FAC PHARM MONTPELLIER,INSERM,CJF 9207,15 AVE CHARLES FLAHAULT,F-34060 MONTPELLIER,FRANCE
[2] FAC PHARM MONTPELLIER,INSERM,U300,F-34060 MONTPELLIER,FRANCE
[3] UNIV PARIS 07,INSERM,U239,F-75018 PARIS,FRANCE
关键词
HGT-1 CELL LINE; GASTRIN; GASTRIN-CCK ANTIBODY; L365,260; PROGLUMIDE; CELL PROLIFERATION;
D O I
10.1016/0303-7207(93)90135-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Gastrin has been shown to promote the growth of some colonic tumor cell lines. To evaluate the involvement of this hormone in the proliferation of gastric tumors, we studied the effects of gastrin/CCK-receptor antagonists (L365,260 and L364,718), proglumide and C terminal-specific gastrin antibodies on the human gastric adenocarcinoma cell line HGT-1. L365,260, but not L364,718, dose-dependently inhibited cell proliferation. (72% after 4 days at 10 nM) and [H-3]thymidine incorporation (68% after 2 days at 10 nM) in serum-free medium. No cytotoxic effects of proglumide or L365,260 on this cell line were detected. Proglumide inhibited cell proliferation in serum-free medium (40% and 66.5% after 2 and 4 days of treatment; IC50 = 1.4 mM) and in 5% fetal calf serum (FCS)-supplemented medium (30% and 22% after 2 and 4 days of treatment; IC50 = 3.25 mM). [H-3]Thymidine incorporation was also inhibited by proglumide in serum-free medium (IC50 = 2.3 mM) and 5% FCS-supplemented medium (IC50 = 3.35 mM). Gastrin did not induce cell proliferation or increase [H-3]thymidine incorporation and no high-affinity gastrin binding sites were observed. However, C terminal-specific gastrin antibodies, even at low concentration, caused a dramatic decrease in both cell number (IC50 = 1:4000 antiserum dilution) and [H-3]thymidine incorporation (IC50 = 1:400 antiserum dilution) in the HGT-1 cell line. In addition, immunofluorescence analysis revealed that these antibodies specifically bind HGT-1 cells and radioimmunoassay analysis confirms the presence of gastrin/CCK-like peptide in cell extracts. Gastrin mRNA was analyzed by Northern blotting with a oligonucleotide probe corresponding to the natural sequence of the human hormone. We found the presence of three main transcripts (1.4, 3.3 and 3.7 kb), two of which were also found in extracts from the antral mucosa. These data strongly support the hypothesis of the presence in the cell of a gastrin/CCK-like peptide which is involved in autocrine or intracrine growth control of this cell line.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 29 条
[1]  
AKIYAMA SK, 1985, J BIOL CHEM, V260, P3256
[2]   PROGLUMIDE, A GASTRIN RECEPTOR ANTAGONIST, INHIBITS GROWTH OF COLON CANCER AND ENHANCES SURVIVAL IN MICE [J].
BEAUCHAMP, RD ;
TOWNSEND, CM ;
SINGH, P ;
GLASS, EJ ;
THOMPSON, JC .
ANNALS OF SURGERY, 1985, 202 (03) :303-309
[3]  
CHANG RSL, 1989, MOL PHARMACOL, V35, P803
[4]  
GUO YS, 1990, IN VITRO CELL DEV B, V26, P871
[5]   PHOSPHORYLATION OF THE FIBRONECTIN RECEPTOR COMPLEX IN CELLS TRANSFORMED BY ONCOGENES THAT ENCODE TYROSINE KINASES [J].
HIRST, R ;
HORWITZ, A ;
BUCK, C ;
ROHRSCHNEIDER, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (17) :6470-6474
[6]  
HOOSEIN NM, 1988, CANCER RES, V48, P7179
[7]   EVIDENCE FOR AUTOCRINE GROWTH-STIMULATION OF CULTURED COLON-TUMOR CELLS BY A GASTRIN CHOLECYSTOKININ-LIKE PEPTIDE [J].
HOOSEIN, NM ;
KIENER, PA ;
CURRY, RC ;
BRATTAIN, MG .
EXPERIMENTAL CELL RESEARCH, 1990, 186 (01) :15-21
[8]   GROWTH OF COLORECTAL-CARCINOMA CELLS - REGULATION INVITRO BY GASTRIN, PENTAGASTRIN AND THE GASTRIN-RECEPTOR ANTAGONIST PROGLUMIDE [J].
IMDAHL, A ;
EGGSTEIN, S ;
CRONE, C ;
FARTHMANN, EH .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (04) :388-392
[9]   GROWTH-RESPONSES OF RAT STOMACH-CANCER CELLS TO GASTROENTEROPANCREATIC HORMONES [J].
KOBORI, O ;
VUILLOT, MT ;
MARTIN, F .
INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (01) :65-67
[10]  
LABOISSE CL, 1982, CANCER RES, V42, P1541